DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Iodo-Willardiine is an investigational drug.
There have been 11 clinical trials for Iodo-Willardiine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 1999.
The most common disease conditions in clinical trials are Neoplasms, Amyloidosis, and Diabetes Mellitus. The leading clinical trial sponsors are National Cancer Institute (NCI), Institut National de la Santé Et de la Recherche Médicale, France, and Institute for Neurodegenerative Disorders.
Recent Clinical Trials for Iodo-Willardiine
|Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]||University of Texas Southwestern Medical Center||N/A|
|Imaging of Advanced Tumours Using I-IAZA||University of Alberta||Phase 1/Phase 2|
|Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases||National Cancer Institute (NCI)||Phase 1|